A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia. Edae CK, Bedada AT, Teklemariam MD, Tolesa MB, et al. PLoS One 2026;21:e0340457.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Edae CK, Bedada AT, Teklemariam MD, Tolesa MB, et al. A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia. PLoS One 2026;21:e0340457.
PMID: 41637421